February 2024 ACIP Meeting Update: Meningococcal, RSV, COVID-19, and Other Vaccines.

Publication date: Mar 29, 2024

The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts that provides advice to the Centers for Disease Control and Prevention, normally meets 3 times per year to develop US vaccine recommendations. The ACIP met February 28 to 29, 2024, to discuss coronavirus disease (COVID-19) vaccines, chikungunya vaccines, DT vaccine, influenza vaccines, polio vaccines, RSV vaccines, meningococcal vaccines, pneumococcal vaccines and Vaxelis (DTaP, Inactivated Poliovirus, Haemophilus influenzae b Conjugate & Hepatitis B Vaccine). This update summarizes the proceedings of these meetings, with an emphasis on topics that are most relevant to the pediatric population. Major updates for pediatric clinicians include information about changes on influenza vaccine composition, meningococcal vaccination considerations, updated guidance for children with a contraindication to pertussis-containing vaccines, and recommendations of the world’s first chikungunya vaccine for certain populations.

Open Access PDF

Concepts Keywords
Clinicians Acip
February Advisory
Meningococcal Chikungunya
Vaccines Committee
Covid
February
Influenza
Meeting
Meningococcal
Pediatric
Recommendations
Rsv
Update
Vaccine
Vaccines

Semantics

Type Source Name
disease MESH COVID-19
disease VO immunization
disease VO vaccine
drug DRUGBANK Methionine
pathway KEGG Coronavirus disease
disease VO influenza vaccines
disease MESH polio
drug DRUGBANK Hepatitis B Vaccine (Recombinant)
disease VO population
disease MESH influenza
disease VO vaccination
disease MESH contraindication
disease MESH pertussis
pathway KEGG Pertussis

Original Article

(Visited 1 times, 1 visits today)